Women's Healthcare Associates dba Rosemark WomenCare Specialists — Idaho Falls, Idaho

Women's Healthcare Associates dba Rosemark WomenCare Specialists is a clinical research site located in Idaho Falls, Idaho, United States 83404.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Women's Healthcare Associates dba Rosemark WomenCare Specialists has participated in 3 clinical trials.

Therapeutic areas: Primary Dysmenorrhea, Overactive Bladder, Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial.

Sponsors: Jiangsu Kanion Pharmaceutical Co., Ltd, Pfizer, AMAG Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Women's Healthcare Associates dba Rosemark WomenCare Specialists?

Women's Healthcare Associates dba Rosemark WomenCare Specialists has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Women's Healthcare Associates dba Rosemark WomenCare Specialists conducted?

Women's Healthcare Associates dba Rosemark WomenCare Specialists has 3 clinical trials on record. Their work covers Primary Dysmenorrhea, Overactive Bladder, Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial.

Is Women's Healthcare Associates dba Rosemark WomenCare Specialists accredited by Crixeo Health?

Women's Healthcare Associates dba Rosemark WomenCare Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Women's Healthcare Associates dba Rosemark WomenCare Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.